Dermatitis This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Interleukin-17 Monoclonal Antibody Successfully Treated Psoriasiform Drug Eruption Induced by Immune Checkpoint Inhibitors: A Case Report and Review of Literature
Dermatitis. 2023 Nov 7. doi: 10.1089/derm.2023.0208. Online ahead of print.NO ABSTRACTPMID:37934278 | DOI:10.1089/derm.2023.0208 (Source: Dermatitis)
Source: Dermatitis - November 7, 2023 Category: Dermatology Authors: Man Li Sebastian Yu Guixiang Zhang Yongxin Xie James Cheng-Chung Wei Source Type: research

Evaluation of Skin Barrier Condition Among Physicians and Dentists
Conclusions: Prolonged glove usage and dental profession, especially surgical work, significantly affect the skin barrier condition. This study was the first to objectively determine skin barrier condition among dentists and physicians.PMID:37934198 | DOI:10.1089/derm.2023.0266 (Source: Dermatitis)
Source: Dermatitis - November 7, 2023 Category: Dermatology Authors: Željka Babić Iva Japund žić-Rapić Liborija Lugovi ć Mihić Jelena Macan Source Type: research

Reading Patch Test Through Line-Field Confocal Optical Coherence Tomography Eyes
Dermatitis. 2023 Nov 7. doi: 10.1089/derm.2023.0117. Online ahead of print.NO ABSTRACTPMID:37934230 | DOI:10.1089/derm.2023.0117 (Source: Dermatitis)
Source: Dermatitis - November 7, 2023 Category: Dermatology Authors: Filomena Russo Laura Lazzeri Francesca Falcinelli Source Type: research

Day 2 Patch Testing Does Not Impact Final Diagnosis in Patch Testing Process
Dermatitis. 2023 Nov 7. doi: 10.1089/derm.2023.0173. Online ahead of print.NO ABSTRACTPMID:37934239 | DOI:10.1089/derm.2023.0173 (Source: Dermatitis)
Source: Dermatitis - November 7, 2023 Category: Dermatology Authors: Mikael Horissian Christen Samaan James Strassner James Marks Source Type: research

Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Observational Study
Conclusions: JAK inhibitors could be considered as effective treatment options for patients with moderate-to-severe AD, particularly upadacitinib, which has shown the greatest efficacy in reducing itching with a favorable safety profile.PMID:37930745 | DOI:10.1089/derm.2023.0132 (Source: Dermatitis)
Source: Dermatitis - November 6, 2023 Category: Dermatology Authors: Dawei Huang Jiajing Lu Fei Tan Source Type: research

Asymptomatic Acute Pancreatitis and Fulminant Type 1 Diabetes Mellitus: A Rare and Life-Threatening Complication in Drug Reaction With Eosinophilia and Systemic Symptoms
Dermatitis. 2023 Nov 1. doi: 10.1089/derm.2023.0217. Online ahead of print.NO ABSTRACTPMID:37910784 | DOI:10.1089/derm.2023.0217 (Source: Dermatitis)
Source: Dermatitis - November 1, 2023 Category: Dermatology Authors: Sarah Benarab Frederic Dezoteux Sarah Stien Valentine Dambricourt Sophie Duvert-Lehembre Source Type: research

Ofloxacin-Induced Genital Bullous Fixed Drug Eruption: A Rare Case of Cross-Reactivity to Multiple Fluoroquinolones
Dermatitis. 2023 Nov 1. doi: 10.1089/derm.2023.0256. Online ahead of print.NO ABSTRACTPMID:37910787 | DOI:10.1089/derm.2023.0256 (Source: Dermatitis)
Source: Dermatitis - November 1, 2023 Category: Dermatology Authors: Raoudha Slim Ferdaous Chahed Bouraoui Ouni Malek Sassi Chaker Ben Salem Neila Fathallah Source Type: research

Atopic Dermatitis and Difficult-to-Treat Areas: A Case Series of Four Patients With Dupilumab-Resistant Primary Atopic Blepharitis and Successfully Treated With Upadacitinib
Dermatitis. 2023 Nov 1. doi: 10.1089/derm.2023.0196. Online ahead of print.NO ABSTRACTPMID:37910788 | DOI:10.1089/derm.2023.0196 (Source: Dermatitis)
Source: Dermatitis - November 1, 2023 Category: Dermatology Authors: Gaetano Licata Vittorio Tancredi Giulia Calabrese Mariachiara Arisi Cesare Ariasi Caterina Mariarosaria Giorgio Source Type: research